Biogen and Ionis report first Phase 2 evidence t
Author: Michael
Harvard Health Publishing’s first longevity re
Scribe Therapeutics has secured clearance from Au
Alzinova is preparing for a global phase II study
MBX Biosciences, Inc.
Biotech firms, including Regenxbio, Novartis and
The Korean Society of Hypertension has incorporat
Korean pharma company targets regenerative medic
Milan panel explores how longevity medicine is s
Sam Altman-backed longevity startup moves deeper